EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Population pharmacokinetics of voriconazole and the role of CYP2C19 genotype on treatment optimization in pediatric patients

Lin Hu iD, Shiqiong Huang, Qi Huang, Juanjuan Huang, Zeying Feng, Gefei He

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0288794 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Lin Hu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The First Hospital of Changsha, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Drug Monitoring, Voriconazole, Antifungal Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this study was to evaluate factors that impact on voriconazole (VRC) population pharmacokinetic (PPK) parameters and explore the optimal dosing regimen for different CYP2C19 genotypes in Chinese paediatric patients. PPK analysis was used to identify the factors contributing to the variability in VRC plasma trough concentrations. A total of 210 VRC trough concentrations from 91 paediatric patients were included in the study. The median VRC trough concentration was 1.23 mg/L (range, 0.02 to 8.58 mg/L). At the measurement of all the trough concentrations, the target range (1.0~5.5 mg/L) was achieved in 52.9% of the patients, while subtherapeutic and supratherapeutic concentrations were obtained in 40.9% and 6.2% of patients, respectively. VRC trough concentrations were adjusted for dose (C trough /D), with normal metabolizers (NMs) and intermediate metabolizers (IMs) having significantly lower levels than poor metabolizers (PMs) ( P N-P < 0.001, P I-P = 0.039). A one-compartment model with first-order absorption and elimination was suitable to describe the VRC pharmacokinetic characteristics. The final model of VRC PPK analysis contained CYP2C19 phenotype as a significant covariate for clearance. Dose simulations suggested that a maintenance dose of 9 mg/kg orally or 8 mg/kg intravenously twice daily was appropriate for NMs to achieve the target concentration. A maintenance dose of 9 mg/kg orally or 5 mg/kg intravenously twice daily was appropriate for IMs. Meanwhile, PMs could use lower maintenance dose and an oral dose of 6 mg/kg twice daily or an intravenous dose of 5mg/kg twice daily was appropriate. To increase the probability of achieving the therapeutic range and improving efficacy, CYP2C19 phenotype can be used to predict VRC trough concentrations and guide dose adjustments in Chinese pediatric patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug MonitoringVoriconazoleAntifungal AgentsAdministration, IntravenousCytochrome P-450 CYP2C19ChildAdministration, OralEast Asian PeopleDose-Response Relationship, DrugHumansGenotype

Substanzen

Antifungal AgentsCYP2C19 protein, humanCytochrome P-450 CYP2C19Voriconazole

Autor:innen und Institutionen

  • Department of Pharmacy, The First Hospital of Changsha, Changsha, Hunan, China.
  • Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Clinical Trial Institution Office, Liuzhou Hospital of Guangzhou Women and Children's Medical Center, Liuzhou, Guangxi, China.
  • Center of Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.

ORCID-Profile: Lin Hu

Förderung

  • Natural Science Foundation of Hunan Province

Zitieren

APA

Hu, L., Huang, S., Huang, Q., Huang, J., Feng, Z., & He, G. (2023). Population pharmacokinetics of voriconazole and the role of CYP2C19 genotype on treatment optimization in pediatric patients. PLOS ONE. https://doi.org/10.1371/journal.pone.0288794

Vancouver

Hu L, Huang S, Huang Q, Huang J, Feng Z, He G. Population pharmacokinetics of voriconazole and the role of CYP2C19 genotype on treatment optimization in pediatric patients. PLOS ONE. 2023. doi:10.1371/journal.pone.0288794

BibTeX
@article{Hu2023,
  author = {Hu, Lin and Huang, Shiqiong and Huang, Qi and Huang, Juanjuan and Feng, Zeying and He, Gefei},
  title = {Population pharmacokinetics of voriconazole and the role of CYP2C19 genotype on treatment optimization in pediatric patients},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0288794}
}
Kostenlos starten →